Sunshine Biopharma Warrant Stock Market Value
| SBFMW Stock | USD 0.21 0.01 4.55% |
| Symbol | Sunshine |
Sunshine Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sunshine Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sunshine Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sunshine Biopharma.
| 08/25/2024 |
| 11/23/2024 |
If you would invest 0.00 in Sunshine Biopharma on August 25, 2024 and sell it all today you would earn a total of 0.00 from holding Sunshine Biopharma Warrant or generate 0.0% return on investment in Sunshine Biopharma over 90 days. Sunshine Biopharma is related to or competes with Sunshine Biopharma, and Neurosense Therapeutics. Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development o... More
Sunshine Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sunshine Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sunshine Biopharma Warrant upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 19.2 | |||
| Information Ratio | 0.1674 | |||
| Maximum Drawdown | 103.27 | |||
| Value At Risk | (28.00) | |||
| Potential Upside | 50.0 |
Sunshine Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sunshine Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sunshine Biopharma's standard deviation. In reality, there are many statistical measures that can use Sunshine Biopharma historical prices to predict the future Sunshine Biopharma's volatility.| Risk Adjusted Performance | 0.1425 | |||
| Jensen Alpha | 4.11 | |||
| Total Risk Alpha | 0.3433 | |||
| Sortino Ratio | 0.1951 | |||
| Treynor Ratio | (1.92) |
Sunshine Biopharma Backtested Returns
Sunshine Biopharma is out of control given 3 months investment horizon. Sunshine Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16% return per unit of risk over the last 3 months. We have collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 3.49% are justified by taking the suggested risk. Use Sunshine Biopharma Risk Adjusted Performance of 0.1425, coefficient of variation of 577.12, and Semi Deviation of 14.88 to evaluate company specific risk that cannot be diversified away. Sunshine Biopharma holds a performance score of 12 on a scale of zero to a hundred. The entity has a beta of -2.01, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Sunshine Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Sunshine Biopharma is expected to outperform it. Use Sunshine Biopharma potential upside, as well as the relationship between the daily balance of power and relative strength index , to analyze future returns on Sunshine Biopharma.
Auto-correlation | 0.20 |
Weak predictability
Sunshine Biopharma Warrant has weak predictability. Overlapping area represents the amount of predictability between Sunshine Biopharma time series from 25th of August 2024 to 9th of October 2024 and 9th of October 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sunshine Biopharma price movement. The serial correlation of 0.2 indicates that over 20.0% of current Sunshine Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.2 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Sunshine Biopharma lagged returns against current returns
Autocorrelation, which is Sunshine Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sunshine Biopharma's stock expected returns. We can calculate the autocorrelation of Sunshine Biopharma returns to help us make a trade decision. For example, suppose you find that Sunshine Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sunshine Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sunshine Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sunshine Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sunshine Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Sunshine Biopharma Lagged Returns
When evaluating Sunshine Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sunshine Biopharma stock have on its future price. Sunshine Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sunshine Biopharma autocorrelation shows the relationship between Sunshine Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Sunshine Biopharma Warrant.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sunshine Stock Analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.